Ardelyx
ARDX
#6603
Rank
โ‚ฌ0.75 B
Marketcap
2,93ย โ‚ฌ
Share price
0.31%
Change (1 day)
-32.72%
Change (1 year)

EPS for Ardelyx (ARDX)

EPS in 2026 (TTM): -0,19ย โ‚ฌ

According to Ardelyx's latest financial reports the company's current EPS (TTM) is -0,20ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,22ย โ‚ฌ a decrease over its 2024 EPS that were of -0,14ย โ‚ฌ.

EPS history for Ardelyx from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,19ย โ‚ฌ-14.42%
2025-0,22ย โ‚ฌ56.25%
2024-0,14ย โ‚ฌ
2022-0,43ย โ‚ฌ-68.42%
2021-1,36ย โ‚ฌ44.76%
2020-0,94ย โ‚ฌ-28.57%
2019-1,31ย โ‚ฌ-9.26%
2018-1,45ย โ‚ฌ19.12%
2017-1,21ย โ‚ฌ
2015-0,99ย โ‚ฌ524.75%
2014-0,16ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
2,78ย โ‚ฌ-1,517.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
14,47ย โ‚ฌ-7,472.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1,70ย โ‚ฌ-964.97%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
5,96ย โ‚ฌ-3,136.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
OPKO Health
OPK
-0,08032ย โ‚ฌ-59.09%๐Ÿ‡บ๐Ÿ‡ธ USA